Floatz logo

Auto-Cd34+ Cells

Ulcer

Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanCell therapyPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Ulcer cohort.

Asset / SponsorPhaseRating
IBUPROFEN
Amgen
Phase 3BB
Famotidine
Amgen
Phase 3BB
NEPENTHE
Soroka University Medical Center
N/AD

Same molecule, other indications

Auto-Cd34+ Cells is also rated in:

myocardial ischemiaDormant
BB
Indicative ·
66 / 100
View asset →
coronary artery disorderDormant
BB
Indicative ·
66 / 100
View asset →
Leg PainDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →